Ralph Gruber

Company: Novartis

Job title: Principal Scientist, Lab Head, Project Team Leader

Seminars:

Emerging Targeted Approaches in Renal Diseases: Pioneering Innovations for 2025 & Beyond 1:30 pm

Delve into the latest advancements in understanding molecular mechanisms driving renal diseases, including fibrosis, inflammation, and metabolic dysfunction, to identify groundbreaking therapeutic targets Examine the journey from target identification to drug development, emphasizing innovative approaches like precision medicine, biologics, and combination therapies tailored to address unmet needs in renal disease populations Consider how emerging technologies,…Read more

day: Day Two PM

Panel Discussion: What’s Next for CKD Therapeutics – Predicting the Future of Innovation & Treatment 2:30 pm

Reflecting on the Current State of CKD Research and Treatment: How are the innovations we’ve explored today shaping the future of CKD treatment, and what areas are poised for the most rapid advancement in the next 5–10 years? Emerging Therapeutics and Combination Therapies: As new therapeutics, like GLP-1 receptor agonists and RAAS inhibitors, gain traction,…Read more

day: Day Two PM